158 related articles for article (PubMed ID: 33250156)
21. Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide.
Lee WS; Nam KH; Kim JH; Kim WJ; Kim JE; Shin EC; Kim GR; Choi JM
Front Immunol; 2023; 14():1233514. PubMed ID: 37818377
[TBL] [Abstract][Full Text] [Related]
22. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
23. Immunohistological localization of BMP-2, BMP-7, and their receptors in knee joints with focal cartilage lesions.
Schmal H; Mehlhorn AT; Pilz IH; Dovi-Akue D; Kirchhoff C; Südkamp NP; Gerlach U; Lohrmann C; Niemeyer P
ScientificWorldJournal; 2012; 2012():467892. PubMed ID: 22272175
[TBL] [Abstract][Full Text] [Related]
24. Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes?
Komine M; Karakawa M; Takekoshi T; Sakurai N; Minatani Y; Mitsui H; Tada Y; Saeki H; Asahina A; Tamaki K
J Invest Dermatol; 2007 Aug; 127(8):1915-22. PubMed ID: 17446902
[TBL] [Abstract][Full Text] [Related]
25. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin.
Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC
Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
[TBL] [Abstract][Full Text] [Related]
27. Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome.
Kotzsch A; Nickel J; Seher A; Heinecke K; van Geersdaele L; Herrmann T; Sebald W; Mueller TD
J Biol Chem; 2008 Feb; 283(9):5876-87. PubMed ID: 18160401
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin Downregulates Psoriatic Inflammation by Its Possible Self-Regulatory Effect on Epidermal Keratinocytes.
Funakoshi A; Tatsuno K; Shimauchi T; Fujiyama T; Ito T; Tokura Y
J Immunol; 2019 May; 202(9):2609-2615. PubMed ID: 30902899
[TBL] [Abstract][Full Text] [Related]
29. Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation.
Günther C; Starke J; Zimmermann N; Schäkel K
Clin Exp Dermatol; 2012 Mar; 37(2):169-76. PubMed ID: 22188261
[TBL] [Abstract][Full Text] [Related]
30. The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis.
Yan K; Han L; Deng H; Fang X; Zhang Z; Huang G; Zheng ZZ; Huang Q; Xu J
J Dermatol Sci; 2018 Oct; 92(1):106-113. PubMed ID: 30072243
[TBL] [Abstract][Full Text] [Related]
31. CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells.
Günther C; Carballido-Perrig N; Kaesler S; Carballido JM; Biedermann T
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):626-34. PubMed ID: 22113484
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous sensitization is limited by in situ inhibition of cutaneous dendritic cell migration through skin-resident regulatory T cells.
Hanakawa S; Kitoh A; Shibuya R; Dainichi T; Nomura T; Honda T; Egawa G; Otsuka A; Nakajima S; Fujita M; Kabashima K
J Allergy Clin Immunol; 2019 Nov; 144(5):1343-1353.e8. PubMed ID: 31194988
[TBL] [Abstract][Full Text] [Related]
33. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.
Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H
J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779
[TBL] [Abstract][Full Text] [Related]
34. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
35. BMPR1a Is Required for the Optimal TGFβ1-Dependent CD207
Hochgerner M; Bauer T; Zyulina V; Glitzner E; Warsi S; Konkel JE; Tam-Amersdorfer C; Chen W; Karlsson S; Sibilia M; Strobl H
J Invest Dermatol; 2022 Sep; 142(9):2446-2454.e3. PubMed ID: 35300973
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions.
Singhatanadgit W; Salih V; Olsen I
J Cell Physiol; 2006 Dec; 209(3):912-22. PubMed ID: 17001689
[TBL] [Abstract][Full Text] [Related]
37. Expression and activation of the BMP-signaling components in human fracture nonunions.
Kloen P; Doty SB; Gordon E; Rubel IF; Goumans MJ; Helfet DL
J Bone Joint Surg Am; 2002 Nov; 84(11):1909-18. PubMed ID: 12429748
[TBL] [Abstract][Full Text] [Related]
38. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
Gorczynski RM
Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis.
Alzahrani KS; Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; El-Sherbeeny AM; Alhoshani AR; Alshammari MA; Alotaibi MR; Al-Harbi MM
Biomed Pharmacother; 2019 Mar; 111():347-358. PubMed ID: 30593001
[TBL] [Abstract][Full Text] [Related]
40. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
